Neurologically normal survival after fibrinolysis during prolonged cardiac arrest: Case report and discussion

Canadian Journal of Emergency Medicine

Volumn 5, Issue 1, 2003, Pages 49-53

  Clark, Kevin ^a   Abu Laban, Riyad B ^a   Zed, Peter J ^a   Graham, Lois ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

cardiac arrest; fibrinolysis; pulmonary embolism; thrombolysis

Indexed keywords

EID: 78649920912     PISSN: 14818035     EISSN: 14818043     Source Type: Journal    
DOI: 10.1017/S1481803500008125     Document Type: Article

References (30)

1. Wood, KE. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest. 2002; 121: 877–905.
2. 7C: A guide to the international ACLS algorithms. Circulation. 2000; 102(suppl I):142–57.
3. Schoenfeld, CN. Pulmonary embolism. In: Tintinalli, JE, Kelen, GD, Stapczynski, JS, editors. Emergency medicine: a comprehensive study guide. New York: McGraw Hill; 2000. p. 396–401.
4. Hyers, TM, Agnelli, G, Hull, R, Morris, TA, Samama, M, Tapson, V, et al. Antithrombotic therapy for venous thromboembolic disease. Chest. 2001; 119(suppl):176S–93S.
5. MacCarthy, P, Worrall, A, McCarthy, G, Davies, J. The use of transthoracic echocardiography to guide thrombolytic therapy during cardiac arrest due to massive pulmonary embolism. Emerg Med J. 2002; 19: 178–9.
6. Goldhaber, SZ, Haire, WD, Feldstein, ML, Miller, M, Toltzis, R, Smith, JL, et al. Alteplase versus heparin in acute pulmonary embolism: randomized trial assessing right-ventricular function and pulmonary perfusion. Lancet. 1993; 341: 507–11.
7. Konstantinides, S, Geibel, A, Heusel, G, Heinrich, R, Kasper, W. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med. 2002; 347 (15):1143–50.
8. Goldhaber, SZ. Thrombolysis for pulmonary embolism. N Engl J Med. 2002; 347(15):1131–2.
9. Kurkciyan, I, Meron, G, Sterz, F, Janata, K, Domanovits, H, Holzer, M, et al. Pulmonary embolism as cause of cardiac arrest: presentation and outcome. Arch Intern Med. 2000; 160: 1529–35.
10. Courtney, DM, Sasser, HC, Pincus, CL, Kline, JA. Pulseless electrical activity with witnessed arrest as a predictor of sudden death from massive pulmonary embolism in outpatients. Resuscitation. 2001; 49: 265–72.
11. Stueven, HA, Aufderheide, T, Waite, EM, Mateer, JR. Electromechanical dissociation: Six years prehospital experience. Resuscitation. 1989; 17: 173–82.
12. Bonnin, MJ, Pepe, PE, Kimball, KT, Clark, PS. Distinct criteria for termination of resuscitation in the out-of-hospital setting. JAMA. 1993; 270: 1457–62.
13. van der Wouw, PA, Koster, RW, Delemarre, BJ, de Vos, R, Lampe-Schoenmaeckers, AJ, Lie, KI. Diagnostic accuracy of transesophageal echocardiography during cardiopulmonary resuscitation. J Am Coll Cardiol. 1997; 30: 780–3.
14. Varriale, P, Maldonado, JM. Echocardiographic observations during inhospital cardiopulmonary resuscitation. Crit Care Med. 1997; 1997: 10.
15. Calinas-Correia, J, Phair, I. Is there a pulse? Resuscitation. 1999; 41: 201–2.
16. Cripps, T, Camm, J. The management of electromechanical dissociation. Resuscitation. 1991; 22: 173–80.
17. Langdon, RW, Swicegood, WR, Schwartz, DA. Thrombolytic therapy of massive pulmonary embolism during prolonged cardiac arrest using recombinant tissue-type plasminogen activator. Ann Emerg Med. 1989; 18(6):678–80.
18. Kohle, W. [Thrombolysis in resuscitated patients with pulmonary embolism.] Anaesthesist. 1984; 33: 469.
19. Scholz, KH, Hilmer, T, Schuster, S, Wojcik, J, Kreuzer, H, Tebbe, U. Thrombolyse bei reanimierten patienten mit lungenembolie (German). Dtsch Med Wschr. 1990; 115: 930–5.
20. Westhoff-Bleck, M. Lysetherapie bie protraheirter kardio-pulmonaler reanimation: nutzen und komplikationen. Z Kardiol. 1991; 80: 139 [137 to 143]
21. Bottiger, BW, Reim, SM, Diezel, G, Bohrer, H, Martin, E. High-dose bolus injection of urokinase: use during cardiopulmonary resuscitation for massive pulmonary embolism. Chest. 1994; 106: 1281–3.
22. Pharo, GH, Andonakakis, A, Chandrasekaren, K, Amron, G, Levitt, JD. Survival from catastrophic intraoperative pulmonary embolism. Anesth Analg. 1995; 81: 188–90.
23. Schulte-Sinkus, D, Standl, T. [Successful resuscitation after bolus injection of tissue-type plasminogen activator in emergency admission.] Anasthesiol Intensivmed Notfallmed Schmerzther. 1998; 33: 124–8.
24. Newman, DH, Greenwald, I, Callaway, CW. Cardiac arrest and the role of thrombolytic agents. Ann Emerg Med. 2000; 35: 472–0.
25. Bottiger, BW, Bode, C, Kern, S, Gries, A, Gust, R, Glatzer, R, et al. Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial. Lancet. 2001; 357: 1583–5.
26. Lederer, W, Lichtenberger, C, Pechlaner, C, Kroesen, G, Baubin, M. Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest. Resuscitation. 2001; 50: 71–6.
27. Abu-Laban, RB, Christenson, JM, Innes, GD, van Beek, CA, Wanger, KP, McKnight, RD, et al. Tissue plasminogen activator in cardiac arrest with pulseless electrical activity. N Engl J Med. 2002; 346: 1522–8.
28. Tiffany, PA, Schultz, M, Steuven, H. Bolus thrombolytic infusions during CPR for patients with refractory arrest rhythms: outcome of a case series. Ann Emerg Med. 1998; 31: 124–6.
29. Bottiger, B, Padosch, SA, Wenzel, V. Tissue plasminogen activator in cardiac arrest with pulseless electrical activity [letter]. N Engl J Med. 2002; 347: 1281.
30. Abu-Laban, RB, Christenson, JM, Innes, GD. Tissue plasminogen activator in cardiac arrest with pulseless electrical activity [letter]. N Engl J Med. 2002; 347: 1282.